1998
DOI: 10.1093/clinchem/44.3.522
|View full text |Cite
|
Sign up to set email alerts
|

Homogeneous assay for measuring low-density lipoprotein cholesterol in serum with triblock copolymer and α-cyclodextrin sulfate

Abstract: We have developed a fully automated method for measuring LDL-cholesterol (LDL-C) in human serum without the need for prior separation, using a nonionic surfactant, polyoxyethylene–polyoxypropylene block copolyether (POE-POP), and a sodium salt of sulfated cyclic maltohexaose, α-cyclodextrin sulfate. Of the surfactants tested, POE-POP with a higher molecular mass of the POP block and a greater hydrophobicity reduced the reactivity of cholesterol in lipoprotein fractions; the reactivity in descending order was L… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
50
0

Year Published

2000
2000
2020
2020

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 102 publications
(50 citation statements)
references
References 18 publications
0
50
0
Order By: Relevance
“…The homogeneous assay uses acyclodextrin sulfate and a nonionic surfactant (polyoxyethylene-polyoxypropylene block copolymer) to block the enzymatic reaction of cholesterol in chylomicrons and VLDL and selectively solubilize LDL without affecting HDL, respectively. 21,22 Non-HDL-C was calculated by subtracting HDL-C from total cholesterol (TC). Fibroblast growth factor 21 (FGF21) level was measured using the enzyme-linked immunosorbent assay with HUMAN FGF21 ELISA (BioVendor, Czech Republic).…”
Section: Clinical Laboratorymentioning
confidence: 99%
“…The homogeneous assay uses acyclodextrin sulfate and a nonionic surfactant (polyoxyethylene-polyoxypropylene block copolymer) to block the enzymatic reaction of cholesterol in chylomicrons and VLDL and selectively solubilize LDL without affecting HDL, respectively. 21,22 Non-HDL-C was calculated by subtracting HDL-C from total cholesterol (TC). Fibroblast growth factor 21 (FGF21) level was measured using the enzyme-linked immunosorbent assay with HUMAN FGF21 ELISA (BioVendor, Czech Republic).…”
Section: Clinical Laboratorymentioning
confidence: 99%
“…HDL-cholesterol (HDL-C) was measured by homogeneous reagent [27] and low-density lipoprotein-cholesterol (LDL-C) was estimated according to the Friedewald formula for triglyceride levels < 4.52 mmol/L [28] . For samples which were found to contain levels of triglyceride > 4.52 mmol/L, LDL-C was directly measured by the homogeneous LDL-C method (Labest -Lagoa Santa -MG, Brazil) [29] . In order to minimize the variation, the direct LDL-C method was used for all serum samples of the patients who had triglyceride > 4.52 mmol/L, i.e., samples collected before and after n-3 PUFA treatment.…”
Section: Laboratory Methodsmentioning
confidence: 99%
“…We dosed HDL-C using method Precipitation with Phosphotungstic acid method in presence of Magnesium ions [20]. The dose of LDL Cholesterol (C-LDL) was performed blocking lipoproteins other than LDL method [21]. Furthermore, only the cholesterol associated to LDL was dosed by Enzymatic Reaction.…”
Section: Determination Of Plasma Lipid Parametersmentioning
confidence: 99%